ASX Share rice
Tue 18 May 2021 - 10:24:am (Sydney)

RSH Share Price

RESPIRI LIMITEDRSHHealth Care Equipment & Services

RSH Company Information

Name:

Respiri Limited

Sector:

Healthcare

Industry:

Medical Devices

GIC Industry:

Health Care Equipment & Supplies

GIC Sub Industry:

Health Care Equipment

Address:

432 St Kilda Road Melbourne VIC Australia 3004

Phone:

61 3 9653 9160

Exec. Chairman:

Mr. Nicholas Smedley

CEO, MD & Exec. Director:

Mr. Marjan Mikel B.Sc., M.A.I.C.D.

Chief Research Officer:

Dr. Samaneh Sarraf Shirazi

Gen. Mang. of Commercial Operations:

Mr. Philippe Ludekens

Operations Mang.:

Mr. Peter Hildebrandt

Vice-Pres of Bus. Devel.:

Ms. Jan P. Barker

Company Sec.:

Mr. Alastair Beard

Medical & Scientific Advisor:

Prof. Noam Gavriely

Medical & Scientific Advisor:

Mr. Simon Godfrey

Company Overview:

Respiri Limited, an e-health SaaS company, researches, develops, and commercializes, medical devices in Australia and Israel. The company produces and sells mobile health applications. Its products include Wheezo, a mobile app, which has asthma management diary, medication usage and reminders, and symptoms and triggers to help asthma sufferers; and Wholter, a device for home ambulatory recording of nocturnal wheeze and cough. The company also offers PulmoTrack, a computerized wheeze detection product designed for hospital/clinical based real-time monitoring of wheeze and cough in the management of acute asthma in the ER and ICU, and for pediatric pulmonary function testing and sleep labs. The company was formerly known as iSonea Limited and changed its name to Respiri Limited in December 2015. Respiri Limited is based in Melbourne, Australia.

RSH Share Price Information

Shares Issued:

722.84M

Market Capitalisation:

$71.56M

Revenue (TTM):

$1.16M

Revenue Per Share (TTM):

$0

Earnings per Share:

$-0.017

Operating Margin (TTM):

$-10.61

Return On Assets (TTM):

$-1.09

Return On Equity (TTM):

$-2.19

Quarterly Revenue Growth (YOY):

-0.461

Gross Profit(TTM):

$2.16M

Diluted Earnings Per Share (TTM):

$-0.019

RSH CashFlow Statement

CashFlow Date:

2020-06-30

Investments:

$-12,863

Change To Liabilities:

$-625,670

Total Cashflow From Investing Activities:

$-12,863

Net Borrowings:

$-146,808

Net Income:

$-7,260,935

Total Cash From Operating Activities:

$-4,687,956

Depreciation:

$10.38K

Change To Inventory:

$-309,219

Change To Account Receivables:

$153.37K

Sale Purchase Of Stock:

$8.53M

Capital Expenditures:

$12.86K

RSH Income Statement

Income Date:

2020-06-30

Income Before Tax:

$-7,260,940

Net Income:

$-7,260,940

Operating Income:

$-7,255,670

Total Revenue:

$2.21M

RSH Balance Sheet

Balance Sheet Date:

2020-06-30

Total Liabilities:

$2.12M

Total Stockholder Equity:

$2.49M

Other Current Liabilities:

$99.96K

Total Assets:

$4.62M

Common Stock:

$113.69M

Other Current Assets:

$366K

Retained Earnings:

$-115,305,935

Other Liabilities:

$128.05K

Other Assets:

$64

Cash:

$3.55M

Total Current Liabilities:

$2M

Short-Term Debt:

$717.14K

Property - Plant & Equipment:

$187.73K

Net Tangible Assets:

$2.49M

Total Current Assets:

$4.43M

Net Receivables:

$8.20K

Short-Term Investments:

$187.79K

Inventory:

$675.22K

Accounts Payable:

$870.44K

Non Currrent Assets (Other):

$64

Short-Term Investments:

$187.79

Non Current Liabilities Total:

$128.05K

RSH Share Price History

RSH News

16 May, 2021
We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...
17 Nov, 2020
Respiri Limited (ASX:RSH) shareholders might be concerned after seeing the share price drop 26% in the last month. But...
20 May, 2020
Taking the occasional loss comes part and parcel with investing on the stock market. Anyone who held Respiri Limited...